{
    "2021-03-18": [
        [
            {
                "time": "2023-03-24",
                "original_text": "药明康德(02359)6269.029万股受限制A股将于3月24日起上市流通 资产查封",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限售股",
                        "上市流通",
                        "资产查封"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-24",
                "original_text": "奥赛康与药明康德达成合作，共同开发 NSCLC 1类新药",
                "features": {
                    "keywords": [
                        "奥赛康",
                        "药明康德",
                        "NSCLC",
                        "1类新药",
                        "合作开发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-24",
                "original_text": "药明康德：6269.029万股非公开发行限售股3月24日上市流通 解禁",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限售股",
                        "上市流通",
                        "解禁"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-24",
                "original_text": "药明康德(603259.SH)：6269.03万股A股限售股将于3月24日起上市流通 解禁",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限售股",
                        "上市流通",
                        "解禁"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "行情回暖，医疗股我们该怎么选？",
                "features": {
                    "keywords": [
                        "行情回暖",
                        "医疗股",
                        "选股策略"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-24",
                "original_text": "药明康德(603259.SH)：6269.029万股限售股3月24日解禁 解禁",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限售股",
                        "解禁"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "奥赛康：子公司与上海药明康德合作开发一类新药",
                "features": {
                    "keywords": [
                        "奥赛康",
                        "药明康德",
                        "合作开发",
                        "一类新药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "奥赛康(002755.SZ)：与上海药明康德合作开发新药并签署合作开发合同书",
                "features": {
                    "keywords": [
                        "奥赛康",
                        "药明康德",
                        "合作开发",
                        "新药",
                        "合同书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "“茅”股连续反弹，最新估值高不高？5张图看清！",
                "features": {
                    "keywords": [
                        "茅股",
                        "反弹",
                        "估值分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药、爱尔眼科、长春高新等医药白马跌至年线，是机会吗？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "爱尔眼科",
                        "长春高新",
                        "医药白马",
                        "年线",
                        "投资机会"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "BlackRock Inc.增持药明康德(02359)38.36万股，每股作价153.38港元",
                "features": {
                    "keywords": [
                        "BlackRock",
                        "增持",
                        "药明康德",
                        "港股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "茅指数持续反弹，美的、海天、迈瑞、药明康德、三一、爱尔眼科涨超2%",
                "features": {
                    "keywords": [
                        "茅指数",
                        "反弹",
                        "药明康德",
                        "涨幅"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[权益变动]药明康德(02359-HK)获贝莱德增持38.36万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "贝莱德",
                        "增持",
                        "权益变动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}